2022
Plasma Menthol Glucuronide as a Biomarker for the Behavioral Effects of Menthol and Nicotine in Humans
Gueorguieva R, Schwartz EKC, MacLean RR, DeVito EE, Eid T, Wu R, O’Malley S, Sofuoglu M. Plasma Menthol Glucuronide as a Biomarker for the Behavioral Effects of Menthol and Nicotine in Humans. Frontiers In Pharmacology 2022, 13: 844824. PMID: 35431934, PMCID: PMC9009207, DOI: 10.3389/fphar.2022.844824.Peer-Reviewed Original ResearchSubjective drug effectsPlasma Mg concentrationHeart rateDrug effectsIntravenous deliveryNon-menthol cigarette smokersPlacebo-controlled studyTest sessionsCigarette smokersMenthol smokersAcute effectsIntravenous nicotineGlucuronide concentrationsMAIN OUTCOMENicotine infusionMenthol glucuronideSecondary analysisPlasma MgE-cigarettesBehavioral effectsMenthol exposureNicotineSmokersPhysiological effectsE-liquids
2016
Effect of Menthol-preferring Status on Response to Intravenous Nicotine
DeVito EE, Valentine GW, Herman AI, Jensen KP, Sofuoglu M. Effect of Menthol-preferring Status on Response to Intravenous Nicotine. Tobacco Regulatory Science 2016, 2: 317-328. PMID: 28890914, PMCID: PMC5589161, DOI: 10.18001/trs.2.4.4.Peer-Reviewed Original ResearchSmoking urgesPre-existing individual differencesNicotine dosesNicotine-dependent participantsOvernight smoking abstinenceShort-term abstinenceNon-menthol cigarettesIndividual differencesCognitive performanceCigarette smokersOvernight abstinenceNon-menthol cigarette smokersAcute nicotineSmokers' responsesDependent participantsSmoking abstinenceSubjective differencesEffect of mentholIntravenous nicotineAbstinenceMenthol preferenceSmokersPRO useParticipantsUrge